Literature DB >> 27377285

Genetic risk factors for venous thrombosis in the elderly in a case-control study.

A Karasu1, M J Engbers1, M Cushman2, F R Rosendaal1,3, A van Hylckama Vlieg4.   

Abstract

UNLABELLED: Essentials Risk of venous thrombosis (VT) related to common genetic variants in those aged 70+ is unknown. We studied Factor V Leiden, prothrombin mutation, non-O blood group and family history (FH) of VT. Risk of VT was increased 2.2-, 1.4-, 1.3- and 2.1-fold respectively. FH is easy to obtain and can be implemented in clinical decision rules of VT risk in the elderly. Click to hear Prof. Reitsma discuss genetic risk factors of arterial and venous thrombosis
SUMMARY: Background As the incidence of venous thrombosis (VT) increases steeply with age and the number of elderly people is on the rise, studies of VT in this age group are important. Objectives We aimed to study the associations of common genetic risk factors (i.e. the factor V Leiden and prothrombin G20210A mutations, non-O blood group and family history of VT) with risk of a first VT in older age (> 70 years). Methods Four hundred and one consecutive cases with a first-time thrombosis and 431 controls (all ≥ 70 years) were included in the AT-AGE case-control study. Information on risk factors for VT, including family history of VT in first-degree relatives, was obtained by interview. Unprovoked VT was defined as thrombosis not related to surgery, fracture, plaster cast or immobility within 3 months prior to VT. Results The risk of VT was 2.2-fold increased in factor V Leiden carriers (95% confidence interval [CI], 1.2-3.9), 1.4-fold increased in prothrombin mutation carriers (95% CI, 0.5-3.9), and 1.3-fold increased in those with non-O blood group (95% CI, 1.0-1.8). Positive family history of VT was associated with a 2.1-fold increased risk of VT (95% CI, 1.5-3.1). The highest risk of VT was found in individuals who had both a positive family history and were carriers of one of the two prothrombotic mutations. Conclusions Genetic factors clearly related to VT in younger populations were also risk factors in older age and a positive family history was also important in this age group.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  ABO blood-group system; aged; factor V Leiden; prothrombin; venous thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27377285     DOI: 10.1111/jth.13409

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Predictive risk factors for venous thromboembolism in neurosurgical patients: A retrospective analysis single center cohort study.

Authors:  Porntip Parmontree; Phanuwat Ketprathum; Teeraphat Ladnok; Supanut Meeaium; Thanyaras Thanaratsiriworakul; Ukrit Sonhorm
Journal:  Ann Med Surg (Lond)       Date:  2022-04-14

Review 2.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

3.  Prevalence of thrombophilia-associated genetic risk factors in blood donors of a regional hospital in southern Brazil.

Authors:  Jéssica Dick-Guareschi; Juliana Cristine Fontana; Maria Teresa Vieira Sanseverino; Francyne Kubaski; Leo Sekine; Nanci Félix Mesquita; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal
Journal:  Hematol Transfus Cell Ther       Date:  2021-03-16

Review 4.  Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis.

Authors:  Qinhong Wang; Rahima Zennadi
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

5.  Procoagulant factor levels and risk of venous thrombosis in the elderly.

Authors:  Huijie Wang; Frits R Rosendaal; Mary Cushman; Astrid van Hylckama Vlieg
Journal:  J Thromb Haemost       Date:  2020-12-22       Impact factor: 5.824

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.